Skip to main content

Table 1 Karyotype and microarray findings in patient

From: Characterization of a case of follicular lymphoma transformed into B-lymphoblastic leukemia

Karyotype Clinically significant aCGH findings Gene-specific alterations (<1 Mb)
84-86<3n>,XXY,+X,+Y,+1,+2,+2,+5, +del(6)(q13)x2,+del(7)(q11.2),-8,-9, +11,-12, add(13)(q31)x2,-15,-17, del(18)(q21.1),+20,+21,+21,+21, +22,+4-6mar[cp10] arr Xp22.33(1-20,008,989)x2,Xp22.12q28(20,008,989-154,876,029)x3,Yp11.32q12(110,058-57,735,230)x2,1p36.33q21.1(356,951-145,048,953)x3,1q21.1q44(145,048,953-246,504,007)x4,2p25.3p11.2(44,198-88,771,193)x2~3,2p11.2(88,771,193-88,939,959)x0~1,2q11.1q12.2(95,004,544-105,862,051)x4,2q12.2q37.3(105,862,051-242,951,149)x2~3,3q25.32q26.31(159,179,678-176,119,209)x4,3q26.31q29(176,182,216-194,089,843)x1,3q29(194,144,086-199,227,915)x2~3,5p15.33q23.1(129,331-120,819,561)x3,5q23.1q23.3(120,866,799-129,327,006)x1,5q23.3q35.3(129,369,711-180,619,169)x3,6p25.3p12.1(128,203-56,479,183)x4,7p22.3p11.1(130,978-57,496,580)x2~3,8p23.3q22.1(177,781-97,839,693)x1,8q24.21q24.3(128,820,805-146,263,042)x2~3,9q12q34.3(69,466,291-140,130,559)x1,11p15.5q25(188,204-134,425,038)x2~3,12q12q21.31(39,127,058-82,868,278)x3,12q24.11q24.12(108,763,306-110,348,984)x1,13q12.11q14.11(18,454,945-40,050,795)x3,13q14.11q21.31(40,056,371-63,246,713)x1,13q31.2q31.3(87,649,097-92,584,929)x5,14q23.3(66,039,131-66,735,897)x3,14q32.33(105,133,180-106,340,244)x1,15q24.2(73,418,043-73,657,137)x1,17p13.3p13.2(49,128-4,959,848)x1,17p13.2p13.1(5,175,207-8,069,489)x1,17p13.1q25.3(8,094,106-78,612,915)x3,18q21.33q23(58,915,605-76,100,854)x1,20p13q13.33(16,653-62,359,694)x3,21q11.2q22.3(14,406,100-46,915,771)x3,22q11.1q11.22(15,912,798-20,879,638)x3,22q11.22(21,356,310-21,571,621)x1,22q11.22q13.2(21,593,777-39,690,567)x3,22q13.2(39,690,567-39,876,284)x>4,22q13.2q13.33(39,876,284-49,691,432)x3 Deletion
NEIL1 (15q24.2)
Copy Gain
GPHN (14q22.3)
Amplification
EP300 (22q13.2)